Search research articles
Contact Us
Filters
Showing results (171-180 of 398) with videos related to
Page
of 40
Sort By:
Lancet (London, England)
|
October 26, 2010
A multilocus genetic risk score for coronary heart disease: case-control and prospective cohort analyses
Samuli Ripatti, Emmi Tikkanen, Marju Orho-Melander, et al.
Plos One
|
November 1, 2008
Gender differences in genetic risk profiles for cardiovascular disease
Kaisa Silander, Mervi Alanne, Kati Kristiansson, et al.
Research Square
|
July 17, 2025
Genetic association of preeclampsia to von Willebrand factor and its size-regulator ADAMTS13
A Inkeri Lokki, Michael Triebwasser, Emma Daly, et al.
The Journal of Clinical Endocrinology and Metabolism
|
April 7, 2022
Circulating Metabolic Biomarkers Are Consistently Associated With Type 2 Diabetes Risk in Asian and European Populations
Jowy Yi Hoong Seah, Yueheng Hong, Anna Cichońska, et al.
European Journal of Anaesthesiology
|
September 17, 2021
Effects of dexmedetomidine, propofol, sevoflurane and S-ketamine on the human metabolome: A randomised trial using nuclear magnetic resonance spectroscopy
Aleksi J Nummela, Lauri T Laaksonen, Timo T Laitio, et al.
Research Square
|
April 3, 2026
Risk Haplotype of BTNL2 Predisposes Male Patients to NSTEMI: A Genetic and Functional Study
A Inkeri Lokki, Juha Sinisalo, Kitty Aierken, et al.
Emerging Themes in Epidemiology
|
November 22, 2013
Data harmonization and federated analysis of population-based studies: the BioSHaRE project
Dany Doiron, Paul Burton, Yannick Marcon, et al.
Atherosclerosis
|
March 2, 2020
Apolipoprotein A-I concentrations and risk of coronary artery disease: A Mendelian randomization study
Minna K Karjalainen, Michael V Holmes, Qin Wang, et al.
Journal of the American College of Cardiology
|
October 6, 2018
Genetic Variants in SGLT1, Glucose Tolerance, and Cardiometabolic Risk
Sara B Seidelmann, Elena Feofanova, Bing Yu, et al.
Clinical Pharmacology and Therapeutics
|
October 4, 2024
Value of Pharmacogenetic Testing Assessed with Real-World Drug Utilization and Genotype Data
Kaisa Litonius, Noora Kulla, Petra Falkenbach, et al.
Page
of 40
Search research articles
Search
Showing results (171-180 of 398) with videos related to
Sort By:
Page
of 40
Lancet (London, England)
|
October 26, 2010
A multilocus genetic risk score for coronary heart disease: case-control and prospective cohort analyses
Samuli Ripatti, Emmi Tikkanen, Marju Orho-Melander, et al.
Plos One
|
November 1, 2008
Gender differences in genetic risk profiles for cardiovascular disease
Kaisa Silander, Mervi Alanne, Kati Kristiansson, et al.
Research Square
|
July 17, 2025
Genetic association of preeclampsia to von Willebrand factor and its size-regulator ADAMTS13
A Inkeri Lokki, Michael Triebwasser, Emma Daly, et al.
The Journal of Clinical Endocrinology and Metabolism
|
April 7, 2022
Circulating Metabolic Biomarkers Are Consistently Associated With Type 2 Diabetes Risk in Asian and European Populations
Jowy Yi Hoong Seah, Yueheng Hong, Anna Cichońska, et al.
European Journal of Anaesthesiology
|
September 17, 2021
Effects of dexmedetomidine, propofol, sevoflurane and S-ketamine on the human metabolome: A randomised trial using nuclear magnetic resonance spectroscopy
Aleksi J Nummela, Lauri T Laaksonen, Timo T Laitio, et al.
Research Square
|
April 3, 2026
Risk Haplotype of BTNL2 Predisposes Male Patients to NSTEMI: A Genetic and Functional Study
A Inkeri Lokki, Juha Sinisalo, Kitty Aierken, et al.
Emerging Themes in Epidemiology
|
November 22, 2013
Data harmonization and federated analysis of population-based studies: the BioSHaRE project
Dany Doiron, Paul Burton, Yannick Marcon, et al.
Atherosclerosis
|
March 2, 2020
Apolipoprotein A-I concentrations and risk of coronary artery disease: A Mendelian randomization study
Minna K Karjalainen, Michael V Holmes, Qin Wang, et al.
Journal of the American College of Cardiology
|
October 6, 2018
Genetic Variants in SGLT1, Glucose Tolerance, and Cardiometabolic Risk
Sara B Seidelmann, Elena Feofanova, Bing Yu, et al.
Clinical Pharmacology and Therapeutics
|
October 4, 2024
Value of Pharmacogenetic Testing Assessed with Real-World Drug Utilization and Genotype Data
Kaisa Litonius, Noora Kulla, Petra Falkenbach, et al.
Page
of 40